Home > Healthcare > Analytical Instruments > Molecular Analysis > PCR Technologies Market

PCR Technologies Market Trends

Report ID: GMI5551
Published Date: May 2024
Report Format: PDF

Download Free Sample

PCR Technologies Market Trends

Molecular diagnostics which is estimated to reach USD 36 billion by 2032, which utilize PCR technologies, are becoming increasingly important in healthcare for their ability to provide rapid and accurate results.
Additionally, the demand for point-of-care testing (POCT) is rising due to the need for decentralized testing in remote areas, clinics, and emergency settings. PCR-based POCT devices enable rapid diagnosis, leading to better patient outcomes and improved disease management.
Further, PCR technologies continue to be at the forefront of biomedical research and development. Researchers are constantly innovating to enhance PCR techniques, develop new assays, and improve the sensitivity and specificity of PCR-based tests.
This ongoing R&D effort drives the adoption of PCR technologies across various fields such as clinical diagnostics, pharmaceuticals, and forensics.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

PCR technologies market size was USD 14.4 billion in 2023 and is expected to register 8.1% CAGR from 2024-2032 owing to the escalating prevalence of infectious diseases and genetic disorders worldwide.

PCR technologies industry from the kits & reagents segment and is expected to reach USD 11.6 billion by 2032 due to the rising demand for accurate molecular diagnostic tests, particularly in infectious diseases and oncology.

The U.S. PCR technologies industry is expected to record USD 10.4 billion by 2032 due to increased investment in biomedical research, significantly supported by government funding initiatives and grants in the region.

Danaher Corporation, Eppendorf SE, F. Hoffmann-LA Roche Ltd., Illumina, Inc., Merck KGaA, New England Biolabs, Promega Corporation, QIAGEN N.V., Standard Biotools Inc., Takara Holdings Inc., and Thermo Fisher Scientific Inc., are some of the major PCR technologies companies worldwide.